References
- Hanifin J M, Lobitz W C, Jr. Newer concepts of atopic dermatitis. Arch Dermatol 1977; 113: 663–70
- Taylor B, et al. Changes in the reported prevalence of childhood eczema following the 1939–1945 war. Lancet 1984; ii: 1255–7
- Langeland T, Fagertun H E, Larsen S. Therapeutic effect of loratadine on pruritus in patients with atopic dermatitis: a multi-crossover-designed study. Allergy 1994; 49: 22–6
- Ring J, et al. Plasma complement and histamine changes in atopic dermatitis. Br J Dermatol 1979; 100: 521–30
- Simons F ER. Evolution of H1-receptor antagonist treatment. Ann Allergy 1993; 71: 282–7
- Monroe E W. Relative efficacy and safety of loratadine, hydroxyzine, and placebo in chronic idiopathic urticaria and atopic dermatitis. Clin Ther 1992; 14: 17–21
- Wahlgren C F, Hägermark ö, Bergström R. The antipruritic effect of a sedative and a non-sedative antihistamine in atopic dermatitis. Br J Dermatol 1990; 122: 545–51
- Hannuksela M, et al. Dose ranging study: cetirizine in the treatment of atopic dermatitis in adults. Ann Allergy 1993; 70: 127–33
- Krause L, Shuster S. Mode of action of H1 antihistamines in itch. Br J Dermatol 1983; 24(suppl)109
- Monroe E. Loratadine in chronic urticaria and atopic skin conditions: a review. Adv Ther 1994; 11(3)95–109
- Campoli-Richards D M, Buckley M M-T, Fitton A. Cetirizine: a review of its pharmacological properties and clinical potential in allergic rhinitis, pollen-induced asthma, and chronic urticaria. Drugs 1990; 40(5)762–81
- Weyer A, et al. In vitro inhibition by loratadine and its active metabolite of anti-IgE induced histamine release from human basophils. J Allergy Clin Immunol 1992; 89: 222
- Chyrek-Borowska S, Siergiejko Z, Michalska I. The effects of a new generation of H1 antihistamines (cetirizine and loratadine) on histamine release and the bronchial response to histamine in atopic patients. J Invest Allergol Clin Immunol 1995; 5(2)103–7
- Andersson M, et al. Suppressive effect of loratadine on allergen-induced histamine release in the nose. Allergy 1991; 46: 540–6
- Simons F ER. H1-receptor antagonists: comparative tolerability and safety. Drug Safety 1994; 40(5)350–80
- Ramaekers J G, Uiterwijk M MC, O'Hanlon J F. Effects of loratadine and cetirizine on actual driving and psychometric test performance, and EEG during driving. Eur J Clin Pharmacol 1992; 42: 363–9
- Herman D, et al. Clinical effectiveness and tolerance of loratadine versus cetirizine in the treatment of seasonal allergic rhinitis. Allerg Immunol 1992; 24(7)270–4
- Pechadre J C, et al. A comparison of central and peripheral effects of cetirizine and loratadine. J Int Med Res 1991; 19: 289–95
- Simons F ER, McMillan J L, Simons K J. A double-blind, single-dose, crossover comparison of cetirizine, terfenadine, loratadine, astemizole, and chlorpheniramine versus placebo: suppressive effects on histamine-induced wheals and flares during 24 hours in normal subjects. J Allergy Clin Immunol 1990; 86: 540–7
- Bédard P M, et al. Onset of action of loratadine and placebo and other efficacy variables in patients with seasonal allergic rhinitis. Clin Ther 1992; 14(2)268–75
- Guerra L, et al. Loratadine and cetirizine in the treatment of chronic urticaria. J Eur Acad Dermatol Venereol 1994; 3: 148–52